<VariationArchive RecordType="classified" VariationID="179126" VariationName="NM_002294.3(LAMP2):c.851_852del (p.Phe284fs)" VariationType="Deletion" Accession="VCV000179126" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2015-01-31" MostRecentSubmission="2015-01-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="176319" VariationID="179126">
      <GeneList>
        <Gene Symbol="LAMP2" FullName="lysosomal associated membrane protein 2" GeneID="3920" HGNC_ID="HGNC:6501" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq24</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="120426148" stop="120469349" display_start="120426148" display_stop="120469349" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="119560002" stop="119603203" display_start="119560002" display_stop="119603203" Strand="-" />
          </Location>
          <OMIM>309060</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LAMP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LAMP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002294.3(LAMP2):c.851_852del (p.Phe284fs)</Name>
      <CanonicalSPDI>NC_000023.11:120446316:AAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq24</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="120446317" stop="120446318" display_start="120446317" display_stop="120446318" variantLength="2" positionVCF="120446316" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="119580172" stop="119580173" display_start="119580172" display_stop="119580173" variantLength="2" positionVCF="119580171" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F284fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002294.2" sequenceAccession="NM_002294" sequenceVersion="2" change="c.851_852delTT">
            <Expression>NM_002294.2:c.851_852delTT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_749" sequenceAccession="LRG_749">
            <Expression>LRG_749:g.28032_28033del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_749t3" sequenceAccession="LRG_749t3">
            <Expression>LRG_749t3:c.851_852del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_749p3" sequenceAccession="LRG_749p3" change="p.Phe284fs">
            <Expression>LRG_749p3:p.Phe284fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_749t2" sequenceAccession="LRG_749t2">
            <Expression>LRG_749t2:c.851_852del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_749p2" sequenceAccession="LRG_749p2" change="p.Phe284fs">
            <Expression>LRG_749p2:p.Phe284fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.119580173_119580174del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.119580173_119580174del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.120446318_120446319del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.120446318_120446319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007995.1" sequenceAccession="NG_007995" sequenceVersion="1" change="g.28032_28033del">
            <Expression>NG_007995.1:g.28032_28033del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122606.1" sequenceAccession="NM_001122606" sequenceVersion="1" change="c.851_852del">
            <Expression>NM_001122606.1:c.851_852del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116078.1" sequenceAccession="NP_001116078" sequenceVersion="1" change="p.Phe284fs">
            <Expression>NP_001116078.1:p.Phe284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002294.3" sequenceAccession="NM_002294" sequenceVersion="3" change="c.851_852del" MANESelect="true">
            <Expression>NM_002294.3:c.851_852del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002285.1" sequenceAccession="NP_002285" sequenceVersion="1" change="p.Phe284fs">
            <Expression>NP_002285.1:p.Phe284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013995.2" sequenceAccession="NM_013995" sequenceVersion="2" change="c.851_852del">
            <Expression>NM_013995.2:c.851_852del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054701.1" sequenceAccession="NP_054701" sequenceVersion="1" change="p.Phe284fs">
            <Expression>NP_054701.1:p.Phe284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA183779" DB="ClinGen" />
        <XRef Type="rs" ID="727504648" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002294.3(LAMP2):c.851_852del (p.Phe284fs) AND Danon disease" Accession="RCV000155911" Version="4">
        <ClassifiedConditionList TraitSetID="2823">
          <ClassifiedCondition DB="MedGen" ID="C0878677">Danon disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-11-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-01-31" MostRecentSubmission="2015-01-31">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2823" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen Storage Disease Type IIb</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOGLYCOGENOSIS II</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IIb</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Danon disease</ElementValue>
                <XRef ID="Danon+Disease/2114" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010281" DB="MONDO" />
                <XRef ID="419097006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vacuolar cardiomyopathy and myopathy X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Antopol disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudoglycogenosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease limited to the heart</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 2b (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal glycogen storage disease without acid maltase deficiency (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD2B (formerly)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD2B</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Danon disease is a multisystem condition with predominant involvement of the heart, skeletal muscles, and retina, with overlying cognitive dysfunction. Males are typically more severely affected than females. Males usually present with childhood onset concentric hypertrophic cardiomyopathy that is progressive and often requires heart transplantation. Rarely, hypertrophic cardiomyopathy can evolve to resemble dilated cardiomyopathy. Most affected males also have cardiac conduction abnormalities. Skeletal muscle weakness may lead to delayed acquisition of motor milestones. Learning disability and intellectual disability, most often in the mild range, are common. Additionally, affected males can develop retinopathy with subsequent visual impairment. The clinical features in females are broader and more variable. Females are more likely to have dilated cardiomyopathy, with a smaller proportion requiring heart transplantation compared to affected males. Cardiac conduction abnormalities, skeletal muscle weakness, mild cognitive impairment, and pigmentary retinopathy are variably seen in affected females.</Attribute>
                <XRef ID="NBK554742" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9730" />
                <XRef ID="9730" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32134616</ID>
                <ID Source="BookShelf">NBK554742</ID>
              </Citation>
              <XRef ID="34587" DB="Orphanet" />
              <XRef ID="C0878677" DB="MedGen" />
              <XRef ID="MONDO:0010281" DB="MONDO" />
              <XRef Type="MIM" ID="300257" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="367718" SubmissionDate="2019-03-21" DateLastUpdated="2015-01-31" DateCreated="2015-01-31">
        <ClinVarSubmissionID localKey="39471309|Orphanet:ORPHA34587" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000205622" DateUpdated="2015-01-31" DateCreated="2015-01-31" Type="SCV" Version="4" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Phe284fs variant in LAMP2 has not been reported in individuals with cardiomy opathy or Danon disease. Data from large population studies is insufficient to a ssess whether this variant is present in the general population. This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at po sition 284 and lead to a premature termination codon 7 amino acids downstream. T his alteration is then predicted to lead to a truncated or absent protein (loss of function; LOF). Heterozygous loss of function of the LAMP2 gene is an establi shed disease mechanism in Danon disease. In summary, this variant meets our crit eria to be classified as pathogenic (http://pcpgm.partners.org/LMM) based on the predicted impact of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_002294.2:EXON 6</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_002294.2:c.851_852delTT</Name>
            <Name>p.Phe284CysfsX7</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.119580172_119580173delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA34587" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="367718" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA34587" MappingRef="Orphanet">
        <MedGen CUI="C0878677" Name="Danon disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

